Deep Tech Meets Clinical Credibility: How we helped Earn the Trust of Enterprise Buyers.
Doctronic | Healthcare AI + Clinical Technology
The Challenge
When Technical Depth Isn't Enough
Following a high-profile Politico feature on its AI-native care delivery model, Doctronic faced direct scrutiny from health plans, institutional partners, and clinical stakeholders. The engineering team had built sophisticated infrastructure, but enterprise buyers were asking harder questions about clinical risk, liability, and edge-case failures. Doctronic had significant data from patient encounters. What they lacked was a structured way to translate that data into evidence that conservative healthcare buyers could evaluate and act on.
Our Approach
Audit existing data
Reviewed patient encounter data with Doctronic's engineering team to identify what was already provable and where gaps existed.
Evidence Strategy, Built to Satisfy Skeptics
Design the validation architecture
Built a methodology that separated technical performance testing from commercial proof metrics, with safety benchmarks mapped to defined clinical scenarios.
Build the evidence roadmap
Structured a scalable framework aligned to actuarial standards and enterprise procurement criteria.
Develop the strategic assets
Translated the framework into two foundational white papers structured for peer review and enterprise buyer conversations
Results
What We Delivered
Evidence generation framework designed to meet actuarial and clinical governance standards.
The Impact of Our Work
Doctronic entered enterprise conversations with documentation that addressed clinical risk directly rather than deflecting it. The framework gave leadership a transparent, structured account of how their system performs and where its boundaries are managed. That shift moved their market position from disruptive black-box tool to accountable, evidence-backed platform, directly targeting the trust barrier slowing their commercial progress.
Validation methodology separating technical testing from commercial metrics.
Safety benchmarks established for defined clinical scenarios.
2 white papers drafted and structured for peer review.
Data audit completed across over 1 million patient encounters alongside the engineering team.
Building groundbreaking healthcare technology is only half the equation. If your product is technically sound but hitting resistance from risk-averse enterprise buyers, the gap is almost always an evidence problem. That is exactly what we are built to solve.